In line with this observation, in a breast cancer model the authors found that the loss of SIAH2 delayed tumor onset, reduced stromal infiltration, increased tumor perfusion through normalized tumor vasculature, decreased production of proangiogenic growth factors and, ultimately, led to an increased sensitivity to chemotherapy [28]. This evidence concerns the gene SIAH2 and neoplasm.